NC DPH: Xylazine (known on the street as Tranq) Abuse Growing. New Exposure Guidance Issued.

    Xylazine abuse in the United States is a growing public health problem. The…

Continue Reading ›

Updates to Requirements For All DEA-Registered Practitioners. What it Means for Your Practice.

Beginning June 27, the DEA registration will require applicants – both new and renewing – to…

Continue Reading ›

Sad, But True. Fentanyl Fatalities Among Children Rising Faster Than Any Other Age Group.

(FAF) This chart compares the increase in synthetic opioid (fentanyl) deaths between children less…

Continue Reading ›

FDA Approves Narcan for Over-the-Counter Sales

  Narcan, a prescription nasal spray that reverses opioid overdoses, can now be sold over the…

Continue Reading ›

Substance Use Prevention Services in Primary Care Challenge Competition

  NIH’s National Institute on Drug Abuse seeks creative, visionary, and actionable plans to…

Continue Reading ›

Updated CME Series in Opioid Prescribing and Responding to Addiction

  The North Carolina Medical Board collaborated with WakeAHEC and the UNC Chapel Hill…

Continue Reading ›

Effective Immediately: SAMHSA No Longer Accepting NOIs.

Section 1262 of the Consolidated Appropriations Act, 2023 (also known as Omnibus bill), removes…

Continue Reading ›

The Changing Face of Fentanyl-Related Deaths

  According to the Families Against Fentanyl organization's website, Fentanyl is now the…

Continue Reading ›

DEA Announces Important Change to Registration Requirement

  On December 29, 2022, with the signing of the Consolidated Appropriations Act of 2023 (the…

Continue Reading ›

With Fentanyl-Related Deaths On Rise, Is It Time for Change In NC Good Samaritan Law?

NCDHHS: Fentanyl-related overdose deaths in NC has increased each year since 2016 when deaths rose…

Continue Reading ›